# The Human Medicines Regulations 2012, Paragraph 3: Approved country for import list on IP completion day (regulation 18A)


(1) For the purposes of regulation 18A(1) (approved country for import), during the transitional period, the licensing authority must publish an approved country for import list that includes each EEA State in it.
(2) The licensing authority must not, before the end of the transitional period, exercise its power under regulation 18A(3) to remove an EEA State from the approved country for import list.
(3) In this paragraph, “the transitional period” is the period of two years beginning with IP completion day.

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/schedule/33A/paragraph/3 (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/schedule-33A/paragraph-3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.